← SynDRA
OXYPURINOL
SynDRA canonical compound SYN0002241 — structure-anchored drug synonym record
| Clinical phase | Phase 2/Phase 3 |
| Primary target(s) | XDH |
| Mechanism of action | Xanthine oxidase inhibitor |
All known targets
Mechanisms of action (all sources)
- Xanthine oxidase inhibitor
- XDH INHIBITOR
- Xanthine dehydrogenase inhibitor
Drug classes
Cross-references
Synonyms
- Oxipurinol
- NSC-76239
- Oxypurinol (intravenous)
- 1H-Pyrazolo[3,4-d]pyrimidine-4,6-diol
- Alloxanthine
- Oxoallopurinol
- DHPP
- 1H-Pyrazolo[3,4-d]pyrimidine-4,6(5H,7H)-dione
- NSC 76239
- Ossipurinolo
- Oxipurinolum
- CHEBI:28315
- 1H-Pyrazolo(3,4-d)pyrimidine-4,6-diol
- G97OZE5068
- 1,2-dihydropyrazolo[3,4-d]pyrimidine-4,6-dione
- 1H-Pyrazolo(3,4-d)pyrimidine,4,6(5H,7H)-dione
- 1H-PYRAZOLO(3,4-D)PYRIMIDINE-4,6(5H,7H)-DIONE
- DTXCID2015209
- 1,7-dihydropyrazolo[3,4-d]pyrimidine-4,6-dione
- NSC76239
- 1H,4H,5H,6H,7H-pyrazolo[3,4-d]pyrimidine-4,6-dione
- 1,2-dihydropyrazolo(3,4-d)pyrimidine-4,6-dione
- 1,7-dihydropyrazolo(3,4-d)pyrimidine-4,6-dione
- 1H,4H,5H,6H,7H-pyrazolo(3,4-d)pyrimidine-4,6-dione
- RefChem:169085
- 4,6-Dihydroxypyrazolo[3,4-d]pyrimidine
- 1H-Pyrazolo[3,4-d]pyrimidine-4,6(2H,5H)-dione
- 2H-Pyrazolo[3,4-d]pyrimidine-4,6(5H,7H)-dione
- Oxypurinol [USAN]
- BW 555
- B. W. 55-5
- MFCD00056934
- Oxipurinol [INN]
- BW 55-5
- 1H,3H,9H-Alloxanthine
- MFCD00047205
- 4,6-Dihydroxypyrazolo(3,4-d)pyrimidine
- 4,6-Dihydroxy-1H-pyrazolo[3,4-d]pyrimidine
Look up OXYPURINOL in the interactive SynDRA portal →